Fred Hassan
Director · BridgeBio Pharma, Inc.
Individual
- 2024
- Jun 24, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Fred Hassan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- Randal J. Kirk - $28.04M in PGEN purchases and sales in the last 12 months
- Jennifer E. Cook - $21.92M in BBIO purchases and sales in the last 12 months
- Andrew Lo - $6.32M in BBIO purchases and sales in the last 12 months
- Andrea Ellis - $5.65M in BBIO purchases and sales in the last 12 months
- Hannah Valantine - $4.37M in BBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fred Hassan?
Fred Hassan is a corporate insider, tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Fred Hassan last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 7 filings going back to 2024.
